Andrew Chou
@AChouMD
Followers
292
Following
3K
Statuses
2K
Christian; dad; ED doc @ucsfdem; via @emhpolicy @yaleem2; tweets on access, care transitions, health insurance, and more; views are my own
Joined October 2016
One of those things you'd think we don't need a trial to show... But sadly we do.
New š out of Canada. āThe findings support a recent call for pharmacoequity, or access to high-quality šš, āregardless of race & ethnicity, socioeconomic status, or availability of resourcesā by demonstrating economic benefits of fair access.ā
0
0
0
@JoeStegemanMD @BWHEmergencyMed @ScottWeinerMD @JSchuurMD @PeterRchai See you in traffic on the bridge. š
0
0
0
AMCs transfer admitted patients to community hosp for capacity management. NHB and Hispanic pts were more likely to be deemed eligible for transfer by MDs and more likely to consent to transfer. Raising Q on systemic bias & need for levers to mediate. #SAEM23 @EMRES_MGHBWH
0
0
5
RT @k_sauser: 180% in utilization of ED observation stays over from 2006/7 - 2018/9. #Neurology complaints were an important driver. Greatā¦
0
2
0
Higher hospital surge preparedness is associated with over one third reduction in excess mortality. #SAEM23 by @AlexJankeMD @arjunvenkatesh Cc @jeremyfaust
0
1
11
RT @muhil_ravi: My name is Muhil, and I first came to the United States when I was 2 years old. Despite living here lawfully for two decadeā¦
0
1K
0
@arjunvenkatesh The real question here is, who is the monster that ripped off only half a sheet. š
0
0
0
RT @arjunvenkatesh: āThis leaves us as a society with an important and difficult questionāhow we will we survive if you go into an emergencā¦
0
2
0
RT @propublica: Doctors at a major US insurance company deny tens of thousands of claims a month without even looking at patientsā files.ā¦
0
9K
0
This is pretty much the only reason for denial and pre-authorization--it's more likely people will just go without insurance or forego care, leading to more profits for insurers.
14/ In one corporate document, Cigna estimated that only 5% of people would appeal a denial resulting from a PXDX review.
0
4
22